New Labcorp Offering Makes Detecting, Measuring Unintentional Gluten Consumption Simple and Effective

Woman putting mask on child to protect from COVID-19

COVID-19 Antibody levels: More may be better

Since the beginning of the COVID-19 pandemic, there’s been a lot of talk about testing. Usually, people are referring to diagnostic testing performed with a nasal swab. However, another type of testing—one that requires a blood test and that you may not know about—has been around nearly the whole time.

That testing is for assessing antibody levels against SARS-CoV-2, the virus that causes COVID-19.

Report on Data Interoperability Measures Will Be Released at HIMSS22

Labcorp Enters Into Strategic Relationship with Prisma Health

March 7, 2022

Walgreens and Labcorp offer at-home COVID-19 PCR test collection kits at no cost nationwide

Collaboration expands access to convenient testing at no cost for eligible individuals DEERFIELD, Ill., and BURLINGTON, N.C., March 7, 2022 – Walgreens and Labcorp, a leading global life sciences company, today announced the nationwide [i] availability of Pixel by Labcorp® [ii] COVID-19 at-home collection kit, a PCR test available through Labcorp OnDemand™, at no cost to individuals who meet clinical guidelines*.

Walgreens and Labcorp Offer At-Home COVID-19 PCR Test Collection Kits At No Cost Nationwide

<span>Detecting measurable residual disease (MRD) in hematological malignancies using flow cytometry</span>
March 4, 2022

Detecting measurable residual disease (MRD) in hematological malignancies using flow cytometry

A patient may be in complete remission during or after a cancer treatment, but a few cancer cells may persist in what is known as residual disease. To better inform prognoses, understand treatment decisions, predict a patient’s overall survival or understand the potential for disease relapse, it is important to have the ability to detect and quantify these malignant cells.

Labcorp Implements Race-Free Equation for Kidney Disease Test